| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 8 | |
| #2 | China | 5 | |
| #3 | United States | 3 | |
| #4 | Australia | 1 | |
| #5 | Hong Kong | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Peptides | |
| #3 | Medical preparations | |
| #4 | Analysing materials | |
| #5 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Fang Lei | 15 |
| #2 | Guo Bingshi | 15 |
| #3 | Wang Zhengyi | 15 |
| #4 | Zang Jingwu | 8 |
| #5 | Cao Wei | 7 |
| #6 | Yang Qiumei | 3 |
| #7 | Xu Weili | 2 |
| #8 | Sung Byungje | 1 |
| #9 | Park Eunyoung | 1 |
| #10 | Yang Yuanyuan | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021027850A1 | Anti-claudin 18.2 and anti-4-1bb bispecific antibodies and uses thereof | |
| WO2021013269A1 | Bifunctional molecules with il-7 activity | |
| CN112041339A | anti-IFNAR 1 antibodies for the treatment of autoimmune diseases | |
| WO2020020307A1 | Anti-cd73 anti-pd-l1 bispecific antibodies |